arrow
I

Ira J. Dunkel

Memorial Sloan Kettering Cancer Center
H指数:63
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

作者更正: 组织细胞性肿瘤中CSF1R和其他受体酪氨酸激酶的激活突变

2026-09-010
PRE
An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13

PD1和免疫通路活性在恶性儿科中枢神经系统(CNS)肿瘤中的最新分析:一项儿科脑肿瘤协作组(PBTC)研究,PBTC-N13

2025-11-010
OAAI
Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test

视网膜母细胞瘤患者接受cfDNA检测中的RB1嵌合现象的检测与特征分析

2025-05-081
PRE
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4

一项关于selumetinib治疗复发性/进展性儿童低级别胶质瘤的PBTC二期研究:Strata 2、5和6,以及Strata 1、3和4的长期结局。

2025-04-170
PRE
REPORT ON PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-029B, A PROSPECTIVE PHASE 2 CLINICAL TRIAL OF SELUMETINIB IN TREATING YOUNG PATIENTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA: NEW RESULTS ON STRATA 2, 5, AND 6 WITH UPDATED LONG-TERM SURVIVAL OUTCOMES ON STRATA 1, 3, AND 4
2024-06-180
OAAI
PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-056: A PHASE 1 STUDY OF THE ADAM-10 INHIBITOR, INCB007839, IN CHILDREN WITH RECURRENT/PROGRESSIVE HIGH-GRADE GLIOMAS TO TARGET MICROENVIRONMENTAL NEUROLOGIN-3
2024-06-180
OAAI
MINIMALLY-INVASIVE MOLECULAR DIAGNOSIS OF INFILTRATING BRAINSTEM GLIOMAS THROUGH CEREBROSPINAL FLUID CELL-FREE DNA SEQUENCING
2024-06-180
OAAI
PHASE 1 STUDY OF THE CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M (SOTIGALIMAB) IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS WITH RECURRENT OR PROGRESSIVE CNS TUMORS AND NEWLY DIAGNOSED BRAIN STEM GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-051; NCT03389802)
2024-06-180
OAAI
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A Report From the Pediatric Brain Tumor Consortium (PBTC-047)

panobinostat在弥漫性内源性桥脑胶质瘤患儿中的I期试验: 小儿脑肿瘤联合会 (PBTC-047) 的报告

2023-08-019
OA
A PHASE 1 STUDY OF SAVOLITINIB IN RECURRENT, PROGRESSIVE, OR REFRACTORY MEDULLOBLASTOMA, HIGH-GRADE GLIOMA, DIFFUSE INTRINSIC PONTINE GLIOMA, AND CENTRAL NERVOUS SYSTEM (CNS) TUMORS HARBORING MET ABERRATIONS: A PEDIATRIC BRAIN TUMOR CONSORTIUM TRIAL
2023-06-120
OAAI
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908
2023-02-2020
OAAI
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
2022-11-1230
OAAI